FDG PET detection of unknown primary tumors

Journal of Nuclear Medicine

Volumn 41, Issue 5, 2000, Pages 816-822

  Bohuslavizki, Karl H ^a   Klutmann, Susanne ^b   Kröger, Sabine ^b   Sonnemann, Uwe ^b   Buchert, Ralph ^b   Werner, Jochen A ^b   Mester, Janos ^b   Clausen, Malte ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b NONE

Author keywords

Cancer of unknown primary; FDG PET; Metastases; Oncology

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TUMOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034020039     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Liu YJ, Lee YT, Hsieh SW, Kuo SH. Presumption of primary sites of neck lymph node metastases on fine needle aspiration cytology. Acta Cytol. 1997;41:1477-1482.
2. Jones AS, Cook JA, Philips DE, Roland NR. Squamous carcinoma presenting as an enlarged cervical lymph node. Cancer. 1993;72:1755-1761.
3. Haynes BF. Enlargement of lymph node and spleen. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's Principles of Internal Medicine. 13th ed. New York, NY: McGraw-Hill; 1994:323-329.
4. van den Brekel MWM, Castelijns JA, Stel HV, et al. Occult metastatic neck disease: detection with US and US-guided fine-needle aspiration cytology. Radiology. 1991;180:457-461.
5. de Braud F, Heilbrun LK, Ahmed K, et al. Metastatic squamous cell carcinoma of an unknown primary localized to the neck: advantages of an aggressive treatment. Cancer. 1989;64:510-515.
6. Leipzig B, Winter ML, Hokanson JA. Cervical nodal metastases of unknown origin. Laryngoscope. 1981;91:593-598.
7. Nordstrom DG, Tewfik HH, Latourette HB. Cervical lymph node metastases from an unknown primary. Radiat Oncol Biol Phys. 1979;5:73-76.
8. Wang RC, Goepfert H, Barber AE, Wolf P. Unknown primary squamous cell carcinoma metastatic to the neck. Arch Otolaryngol Head Neck Surg. 1990;116: 1388-1393.
9. Barrie JR, Knapper WH, Strong EW. Cervical nodal metastases of unknown origin. Am J Surg. 1970;120:466-470.
10. Davidson BJ, Spiro RH, Patel S, Patel K, Shah JP. Cervical metastases of occult origin: the impact of combined modality therapy. Am J Surg. 1994;168:395-399.
11. Glynne-Jones RGT, Anand AK, Young TE, Berry RJ, Phil D. Metastatic carcinoma in the cervical lymph nodes from an occult primary: a conservative approach to the role of radiotherapy. J Rad Oncol Biol Phys. 1990;18:289-294.
12. Spiro RH, de Rose G, Strong EW. Cervical node metastasis of occult origin. Am J Surg. 1983;146:441-446.
13. Yang ZY, Hu JH, Yan JH, et al. Lymph node metastases in the neck from an unknown primary: report on 113 patients. Acta Radiol Oncol. 1983;22:17-22.
14. Jones AS, Phillips DE, Helliwell TR, Roland NJ. Occult metastases in head and neck squamous carcinoma. Eur Arch Otorhinolaryngol. 1993;250:446-449.
15. Schipper JH, Schrader M, Arweiler D, Müller S, Sctuk J. Value of positron emission tomography in patients with cervical metastases but unknown primary tumor site [in German]. HNO. 1996;44:254-257.
16. Snee PM, Vyramuthu N. Metastatic carcinoma from unknown primary site: the experience of a large oncology centre. Br J Radiol. 1985;58:1091-1095.
17. Snow GB, Patel P, Leemans CR, Tiwari R. Management of cervical lymph nodes in patients with head and neck cancer. Arch Otorhinolaryngol. 1992;249:187-194.
18. Clarke RW, Stell PM. Squamous carcinoma of head and neck in the young adult. Clin Otolaryngol. 1992;17:18-23.
19. 18F] fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr. 1993;17:582-589.
20. Minn H, Lapela M, Klemi PJ, et al. Prediction of survival with fluorine-18-fluorodeoxyglucose and PET in head and neck cancer. J Nucl Med. 1997;38:1907-1911.
21. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]-fluoro-D-glucose PET and MR imaging diagnoses. Radiology. 1996;200:135-141.
22. Manusco AA, Drane WE, Mukheriji SK. The promise FDG in diagnosis and surveillance of head and neck cancer [editorial]. Cancer. 1994;74:1193-1195.
23. Rege S, Maass A, Chaiken L, et al. Use of positron emission tomography with fiuorodeoxyglucose in patients with extracranial head and neck cancers. Cancer. 1994;73:3047-3058.
24. Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Chest. 1993;104:997-1002.
25. Hübner KF, Buonocore E, Singh SK, Gould HR, Cotten DW. Characterization of chest masses by FDG positron emission tomography. Clin Nucl Med. 1995;20:293-298.
26. Knight SB, Delbeke D, Stewart JR, Sandler MP. Evaluation of pulmonary lesions with FDG-PET. Chest. 1996;109:982-988.
27. Holder WDJ, White RLJ, Zuger JH, Easton EJJ, Greene FL. Effectiveness of positron emission tomography for the detection of melanoma metastases. Ann Surg. 1998;227:764-769.
28. 18F]-FDG positron emission tomography in primary breast cancer: clinical relevance and practicability. Eur J Nucl Med. 1996;23:618-623.
29. Bleckmann C, Buchert R, Schulte U, et al. Lesion detection in oncological PET studies: computer display versus standardized documentation on film [in German]. Nuklearmedizin. 1999;38:56-60.
30. Diggs CH. Cancer of unknown primary site: deciding how far to carry evaluation. Postgrad Med. 1989;86:186-191.
31. Schlag PM, Hunerbein M. Cancer of unknown primary site. Ann Chir Gynaecol. 1994;83:8-12.
32. Schapira DV, Jarrett AR. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma. Arch Intern Med. 1995;155:2050-2054.
33. Muir C. Cancer of unknown primary site. Cancer. 1995;75:353-356.
34. Le Chevalier T, Cvitkovic E, Caille P, et al. Early metastatic cancer of unknown primary origin at presentation: a clinical study of 302 consecutive autopsied patients. Arch Intern Med. 1988;148:2035-2039.
35. Hainsworth JD, Greco FA. Treatment of patients with cancer of an unknown primary site. N Engl J Med. 1993;329:257-263.
36. Jacobs CD, Pinto HA. Head and neck cancer with an occult primary tumor. N Engl J Med. 1992;326:58-59.
37. Reddy SP, Marks JE. Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck dissection. Int J Rad Oncol Biol Phys. 1997;37:797-802.
38. Maiche AG. Cancer of unknown primary: a retrospective study based on 109 patients. Am J Clin Oncol. 1993;16:26-29.
39. Braams JW, Pruim J, Kole AC, et al. Detection of unknown primary head and neck tumors by positron emission tomography. Int J Oral Maxillofac Surg. 1997;26:112-115.
40. Kole AC, Nieweg OE, Pruim J, et al. Detection of unknown occult primary tumors using positron emission tomography. Cancer. 1998;82:1160-1166.